Results 201 to 210 of about 5,128,983 (251)

Serum proteomics mirrors the histopathological changes underlying different etiologies of primary mitral valve disease. [PDF]

Biosci Rep
Garcia-Peña A, Ibarrola J, Segur M, Navarro A, Sádaba A, Tiraplegui C, Garaikoetxea M, Martín-Núñez E, Fernández-Celis A, Sádaba R, Alvarez V, Jover E, López-Andrés N.   +12 more
europepmc   +1 more source

Permanent Cardiac Pacing in Children: A 30‐Year Follow‐Up Retrospective Study in a Single Pediatric Asian Center

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
This 30‐year retrospective study of pediatric permanent pacing found acceptable long‐term device complication rates, with epicardial leads used predominantly. Pacing‐induced cardiomyopathy occurred only in children with congenital heart disease, highlighting the need for individualized pacing strategies in this cohort and long‐term echocardiographic ...
Jiahui Charmaine Chan, Dyan Zhewei Zhang, Koh Zhi Xuan, Sreekanthan Sundararaghavan, Jonathan Tze Liang Choo, Kah Leng Ho, Eric Tien Siang Lim, Ju Le Tan, Nurhafizah Binte Abdul Aziz, Wan Ting Chan, Monika Kotecha, Jan Hau Lee, Teng Hong Tan   +12 more
wiley   +1 more source

Outcomes of mitral valve repair in dogs with myxomatous mitral valve disease and preoperative atrial fibrillation. [PDF]

J Vet Intern Med
Kurogochi K, Endo A, Nishiyama M, Uechi M.   +3 more
europepmc   +1 more source

Clinical Vulnerability Refines Rhythm‐Related Outcomes in Older Patients Undergoing Pulmonary Vein Isolation for Atrial Fibrillation: An Observational Cohort Study

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
In patients undergoing pulmonary vein isolation, age ≥ 75 years was associated with greater recurrence‐related rhythm intervention. However, outcomes varied markedly among older adults. A simple score incorporating persistent AF, heart failure, chronic kidney disease, and valve disease identified elderly patients with low or high clinical vulnerability.
Yazan Mohsen, Jascha Fernholz, Lucas Steffens, Iryna Novikov, Shreeram Sabareesan, Ishan Vatsaraj, Kensuke Sakata, Moritz Knitter, Henning Horlitz, Marc Horlitz, Mustafa Zakkar, Riyaz Somani, G. Andre Ng, Dennis Rottländer, Florian Stöckigt, Ibrahim Antoun   +15 more
wiley   +1 more source

Umbrella-like systolic billowing of redundant mitral leaflets on left ventriculography in barlow mitral valve disease. [PDF]

Eur Heart J Imaging Methods Pract
Nishi T, Kalavakunta JK, Akula A, Saltiel F.   +3 more
europepmc   +1 more source

Clinical Characteristics and Timing of Accessory Pathway Reconduction During Catheter Ablation of Accessory Pathways

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
Intra‐procedural accessory pathway reconduction occurred in 18% of patients, with 65.2% of events detected ≥ 15 min after initial pathway elimination. Reconduction was associated with a higher rate of late recurrence, supporting careful assessment for conduction recovery during the post‐ablation waiting period.
Wataru Sasaki, Hitoshi Mori, Daisuke Kawano, Kei Matsumoto, Naomichi Tanaka, Tsukasa Naganuma, Masataka Narita, Kazuhisa Matsumoto, Yoshifumi Ikeda, Takahide Arai, Shintaro Nakano, Ritsushi Kato   +11 more
wiley   +1 more source

Cryoablation and radiofrequency ablation during mitral valve surgery for rheumatic mitral valve disease: a retrospective cohort study. [PDF]

Front Cardiovasc Med
Nurbay Z, Dzhumabekov A, Kuanishbekova R, Tuleutayev R, Musrepov N.   +4 more
europepmc   +1 more source

Effect of pimobendan on mitral annular dynamics and mitral regurgitation in dogs with myxomatous mitral valve disease as determined by cardiac computed tomography. [PDF]

J Vet Intern Med
Bernard Chi IJ, Scansen BA, Orton EC.
europepmc   +1 more source

Pulmonary artery catheters or central venous catheters for cardiac surgery: the PUMA Pilot randomised clinical trial

Anaesthesia, Volume 81, Issue 10, Page 1358-1366, October 2026.
Summary Introduction Pulmonary artery catheters are used widely in cardiac surgery despite observed associations with worse outcomes and guidelines that recommend against their routine use. No adequately powered randomised trials are available. Methods The PUMA Pilot was a multicentre, randomised, parallel assignment, open‐label, pilot and feasibility ...
Luke A. Perry, Reny Segal, Marco Larobina, Rinaldo Bellomo, Julian A. Smith, Jesselyn Sin, Katrina Danial, Alistair R. D. McLean, Lisa Q. Rong, Mario Gaudino, Thomas Schwann, Marie Palumbo, Luke O'Halloran, Brian Chee, Jinesh Patel, Andrew Silvers, Jayme Bennetts, Silvana Marasco, Tim G. Coulson, Alistair Royse, Emily See, Lachlan F. Miles, on behalf of the ANZCA Clinical Trials Network   +22 more
wiley   +1 more source

Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease. [PDF]

Vet Med Sci
Pirintr P, Limprasutr V, Rungsipipat A, Rattanapinyopituk K, Sawangkoon S, Saengklub N, Kijtawornrat A.   +6 more
europepmc   +1 more source